Exact Mass: 500.0991

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

Lyoniresinol 9-sulfate is found in green vegetables. Lyoniresinol 9-sulfate is a constituent of the roots of Polygonum cuspidatum (Japanese knotweed).

Curtisian P

C29H24O8 (500.1471)

Gnetuhainin J

C29H24O8 (500.1471)

Puerarin 4,6-diacetate

C25H24O11 (500.1319)

Guibourtinidol-(4alpha-

C29H24O8 (500.1471)

Malibatol B

C28H20O9 (500.1107)

Gericudranin D

C29H24O8 (500.1471)

Apigenin 7-(6-crotonylglucoside)

C25H24O11 (500.1319)

2,3-di-O-Acetylfrangulin A

C25H24O11 (500.1319)

Epigallocatechin 5,3,5-trimethyl ether 3-O-gallate

C25H24O11 (500.1319)

16198-01-9

C25H24O11 (500.1319)

delphinidin-3-O-galactoside

C21H21ClO12 (500.0721)

Penta-Ac-2,3,4,4,5-Pentahydroxyflavan

C25H24O11 (500.1319)

Trichochrome F

C22H20N4O6S2 (500.0824)

3-(2,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

3-(3,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

(betaS,2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-beta-(2,4,5-trihydroxyphenyl)-2H-1-benzopyran-6-propanoic acid methyl ester|6-[(1S)-3-methoxy-3-oxo-1-(2,4,5-trihydroxyphenyl)propyl]catechin

C25H24O11 (500.1319)

Penta-Ac-Nubigenol

C25H24O11 (500.1319)

gnetoflavanol E

C29H24O8 (500.1471)

Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene

C29H24O8 (500.1471)

gneafricanin A

C29H24O8 (500.1471)

Curguligine B

C19H26Cl2O11 (500.0852)

(+)-gallocatechin-8-S-beta-D-glucopyranoside|excoecariphenol B

C21H24O12S (500.0988)

rel-(2R,3R)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(4-O-sulfo-alpha-L-arabinopyranosyl)oxy]-4H-1-benzopyran-4-one|trans-2,3-dihydrokaempferol 3-O-(4-O-sulfo)-alpha-L-arabinopyranoside

C20H20O13S (500.0625)

6-(beta-D-glucopyranosyl)oxy-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-2H-1-benzopyran-2-one|daphneretusin A

C24H20O12 (500.0955)

gnaphaffine A

C25H24O11 (500.1319)

6,7-dihydroxy-3-methoxy-8-[2-oxo-2H-1-benzopyran-7-(O-beta-D-glucopyranosyl)-8-yl]-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

Trichochrome E

C22H20N4O6S2 (500.0824)

3-O-p-coumaroyl-5-O-caffeoylquinic acid|3-p-(E)-coumaroyl-5-(E)-caffeoylquinic acid

C25H24O11 (500.1319)

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinic acid

C25H24O11 (500.1319)

Tri-Ac-Menegazziaic acid

C24H20O12 (500.0955)

Chloroenhydrin

C23H29ClO10 (500.1449)

2,4,6-trihydroxybenzoic acid-4-O-2,3,4,6-tetraacetylglucoside

C21H24O14 (500.1166)

gnetoflavanol B

C29H24O8 (500.1471)

Penta-Ac-(-)-3,4,4,5,7-Pentahydroxyflavan

C25H24O11 (500.1319)

7-O-[beta-D-glucopyranosyl]-6-hydroxy-3-(2-oxo-2H-1-benzopyran-7-yl)-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

gneafricanin B

C29H24O8 (500.1471)

(2R,3R)-7,4-dihydroxy-5,3,5-trimethoxyflavan-3-O-gallate

C25H24O11 (500.1319)

5-Carboxypyranopelargonidin 3-O-beta-glucopyranoside

C24H20O12 (500.0955)

Myrtillin

C21H21ClO12 (500.0721)

Delphinidin-3-glucoside is an anthocyanidin glycoside. See also: Myrciaria dubia fruit (part of). Delphinidin 3-glucoside chloride (Delphinidin 3-O-glucoside chloride) is an active anthocyanin found in Hibiscus sabdariffa extract. Delphinidin 3-glucoside chloride induces a pro-apoptotic effect in B cell chronic lymphocytic leukaemia (B CLL)[1]. Delphinidin 3-glucoside chloride exerts phytoestrogen activity by binding to ERβ, with an IC50 of 9.7 μM[2]. Delphinidin-3-O-glucoside chloride inhibits EGFR with an IC50 of 2.37 μM[3]. Delphinidin 3-glucoside chloride (Delphinidin 3-O-glucoside chloride) is an active anthocyanin found in Hibiscus sabdariffa extract. Delphinidin 3-glucoside chloride induces a pro-apoptotic effect in B cell chronic lymphocytic leukaemia (B CLL)[1]. Delphinidin 3-glucoside chloride exerts phytoestrogen activity by binding to ERβ, with an IC50 of 9.7 μM[2]. Delphinidin-3-O-glucoside chloride inhibits EGFR with an IC50 of 2.37 μM[3]. Delphinidin 3-glucoside chloride exhibits antitumor effects through pAKT/IRF1/HOTAIR pathway. Delphinidin 3-glucoside chloride exhibits efficacy against oxidative stress, inhibits platelet activation and endothelial dysfunction[4][5][6]. Delphinidin 3-glucoside chloride (Delphinidin 3-O-glucoside chloride) is an active anthocyanin found in Hibiscus sabdariffa extract. Delphinidin 3-glucoside chloride induces a pro-apoptotic effect in B cell chronic lymphocytic leukaemia (B CLL)[1]. Delphinidin 3-glucoside chloride exerts phytoestrogen activity by binding to ERβ, with an IC50 of 9.7 μM[2]. Delphinidin-3-O-glucoside chloride inhibits EGFR with an IC50 of 2.37 μM[3].

Empetrin

C21H21ClO12 (500.0721)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

Catechin pentaacetate

C25H24O11 (500.1319)

Epicatechin Pentaacetate

C25H24O11 (500.1319)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based on: CCMSLIB00000846875]

C24H20O12 (500.0955)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]

C24H20O12 (500.0955)

Catechin Pentaacetate_major

C25H24O11 (500.1319)

Catechin Pentaacetate_0.7\\%

C25H24O11 (500.1319)

Cys Cys Glu Phe

C20H28N4O7S2 (500.1399)

Cys Cys Phe Glu

C20H28N4O7S2 (500.1399)

Cys Glu Cys Phe

C20H28N4O7S2 (500.1399)

Cys Glu Phe Cys

C20H28N4O7S2 (500.1399)

Cys Phe Cys Glu

C20H28N4O7S2 (500.1399)

Cys Phe Glu Cys

C20H28N4O7S2 (500.1399)

Glu Cys Cys Phe

C20H28N4O7S2 (500.1399)

Glu Cys Phe Cys

C20H28N4O7S2 (500.1399)

Glu Phe Cys Cys

C20H28N4O7S2 (500.1399)

Phe Cys Cys Glu

C20H28N4O7S2 (500.1399)

Phe Cys Glu Cys

C20H28N4O7S2 (500.1399)

Phe Glu Cys Cys

C20H28N4O7S2 (500.1399)

EUK 118

C22H25MnN2O8 (500.0991)

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

TMRM Perchlorate

C25H25ClN2O7 (500.135)

Demeclocycline hydrochloride

C21H22Cl2N2O8 (500.0753)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Demeclocycline hydrochloride is a tetracycline antibiotic; is an antibiotic in the treatment of Lyme disease, acne, and bronchitis.

Sibenadet hydrochloride

C22H29ClN2O5S2 (500.1206)

ICI 204,448 hydrochloride

C23H27Cl3N2O4 (500.1036)

ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes[1].

2,2,2-Triphenyl-1,3,2λ5-dioxabismetan-4-one

C19H15BiO3 (500.0825)

Pitavastatin calcium

C25H23FNO4.1/2 Ca (500.0863)

Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].

METHYL 2-(4-((3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHYNYL)-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YL)-3-METHOXYACRYLATE

C20H13F9N2O3 (500.0782)

MAGNESIUM 4-NITROBENZYL MALONATE

C20H16MgN2O12 (500.0554)

Teclozan

C20H28Cl4N2O4 (500.0803)

P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AC - Dichloroacetamide derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

4-hexyl-2-(4-hexyl-5-thiophen-2-yl-1,3-thiazol-2-yl)-5-thiophen-2-yl-1,3-thiazole

C26H32N2S4 (500.1448)

Regorafenib Monohydrate

C21H17ClF4N4O4 (500.0874)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].

6-Hydroxy Warfarin β-D-Glucuronide

C25H24O11 (500.1319)

Uredofos

C19H25N4O6PS2 (500.0953)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

8-BroMo-5-O-(4-cyanobenzyl)-2,3-O-isopropylidene adenosine

C21H21BrN6O4 (500.0808)

5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID

C27H34BrO2P (500.148)

(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester

C28H24N2O5S (500.1406)

saflufenacil

C17H17ClF4N4O5S (500.0544)

Anhydrous magnesium mono-p-nitrobenzyl malonate

C20H16MgN2O12 (500.0554)

Benzoic acid, 4-(((2,3-dihydro-6-((2-methylpropyl)(2-thiazolylsulfonyl)amino)-1H-inden-5-yl)oxy)methyl)-3-methyl-

C25H28N2O5S2 (500.144)

(+)-Neocarzinostatin chromophore aglycone

C28H20O9 (500.1107)

CMP-5-3-(N-acetyl-N-hydroxy)aminopropylphosphonate

C14H22N4O12P2-2 (500.0709)

2-glutathion-S-yl-3-(4-nitrophenyl) propionic acid

C19H24N4O10S (500.1213)

GS-Hpv II

C20H26N3O10S- (500.1339)

GS-Hpv I

C20H26N3O10S- (500.1339)

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

2-amino-6-O-(2-amino-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl)-2-deoxy-1-O-phosphono-alpha-D-glucopyranose

C12H26N2O15P2 (500.0808)

(3-Chloro-1-benzothiophen-2-yl)-[2-(2-chloro-6-methylphenyl)imino-4-methylene-3-thia-1-azaspiro[4.5]decan-1-yl]methanone

C25H22Cl2N2OS2 (500.0551)

[4-[(2-Chlorophenyl)methylsulfonyl]-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

C23H21ClN4O5S (500.0921)

2-(4-morpholinyl)-9-(3-thiophenyl)-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]-6-purinamine

C22H19F3N8OS (500.1355)

2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

(beta-D-glucopyranosyloxymethyl)deoxyuridine 5-monophosphate

C16H25N2O14P (500.1043)

A pyrimidine 2-deoxyribonucleoside 5-monophosphate having beta-D-glucopyranosyloxymethyluracil (base J) as the nucleobase

Glu-Phe-Cys-Cys

C20H28N4O7S2 (500.1399)

6-({5-[3-(2H-1,3-benzodioxol-5-yl)-3-oxopropanoyl]-1-benzofuran-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H20O12 (500.0955)

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

6-Hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

Lyoniresinol 9-sulfate

C22H28O11S (500.1352)

beta-GlcN-4P-(1->6)-alpha-D-GlcN-1P

C12H26N2O15P2 (500.0808)

A 1,4-bisphosphorylated glucosamine disaccharide corresponding to the carbohydrate portion of E. coli J-5 lipid A.

ST 22:5;O8;S

C22H28O11S (500.1352)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

(11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-8,11-diol

C29H24O8 (500.1471)

5-[(2s,3s)-7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(1e,2r,3r)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3s)-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C21H24O12S (500.0988)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(8s,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(4s,5s,11s,12r)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

methyl (3s)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

(1z,2s,3s)-3-(3,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3r,4r)-4-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

(2s,3s,4s,5r,6s)-3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

2,6-dihydroxy-4-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-phenylpropanoate

C29H24O8 (500.1471)

16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

4-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

C29H24O8 (500.1471)

methyl 3-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

(2r,3s)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

methyl (3r)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

(1e,2s,3s)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

5-[11-(2,4-dihydroxyphenyl)-12-(3,5-dihydroxyphenyl)-8-hydroxy-5,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,3,6,8-tetraen-4-yl]benzene-1,3-diol

C28H20O9 (500.1107)

(11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(4s,5s,11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-but-2-enoate

C25H24O11 (500.1319)

6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl)methyl but-2-enoate

C25H24O11 (500.1319)

(2r,3r)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(5r,6r,11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

(1r,3r,4s,5r)-3-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,5-dihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid

C25H24O11 (500.1319)

3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

(8s,9r)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

5-{7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol

C29H24O8 (500.1471)

(2s,3r,4r,5r,6s)-5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(1r,2s,3e)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methylidene]-1,2-dihydroindene-5,6-diol

C29H24O8 (500.1471)

(2r,3r)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

(8r,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

2-(2,4-dichloro-5-methoxy-3-methylphenoxy)-6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C19H26Cl2O11 (500.0852)

2,6-dihydroxy-4-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)